Britain's medicines regulator has said it has approved the Covid-19 vaccine developed by Pfizer/BioNTech for use on 12 to 15-year-olds, following similar clearances in the US and the EU.
The regulator said it would now be up to the country's Joint Committee on Vaccination and Immunisation (JCVI) to decide whether to go ahead and inoculate this age group as part of Britain's vaccination roll-out plan.
Children aged 12-15 are already receiving the Pfizer shot in the United States, while France and Germany are planning to start offering it to that age group this month.
Britain's Health and Social Care department said it would provide an update once the JCVI had made its decision. The chief executive of the UK Medicines and Healthcare products